Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Considering the facts that: (i) IPT of malaria provides substantial protection against
anaemia and malaria in school children (ii); SP resistance has no significant impact on the
prophylactic efficacy (iii) SP-PQ is safe and as efficacious as SP: the investigators
hypothesize that antimalarial IPT with SP and SP-PQ will improve haemoglobin concentration,
reduce anaemia prevalence, malaria incidence and parasitaemia, and improve malnutrition and
school performance in school-aged children of Congo.
Phase:
Phase 3
Details
Lead Sponsor:
Universiteit Antwerpen
Collaborators:
Fund for Scientific Research, Flanders, Belgium University of Kinshasa
Treatments:
Albendazole Fanasil, pyrimethamine drug combination Piperaquine Praziquantel Pyrimethamine Sulfadoxine Triclabendazole